These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Strategies for Identifying Patients for Deprescribing of Blood Pressure Medications in Routine Practice: An Evidence Review. Sheppard JP; Benetos A; Bogaerts J; Gnjidic D; McManus RJ Curr Hypertens Rep; 2024 May; 26(5):225-236. PubMed ID: 38305846 [TBL] [Abstract][Full Text] [Related]
3. Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older: The OPTIMISE Randomized Clinical Trial. Sheppard JP; Burt J; Lown M; Temple E; Lowe R; Fraser R; Allen J; Ford GA; Heneghan C; Hobbs FDR; Jowett S; Kodabuckus S; Little P; Mant J; Mollison J; Payne RA; Williams M; Yu LM; McManus RJ; JAMA; 2020 May; 323(20):2039-2051. PubMed ID: 32453368 [TBL] [Abstract][Full Text] [Related]
4. The value of deprescribing in older adults with dementia: a narrative review. Sawan MJ; Moga DC; Ma MJ; Ng JC; Johnell K; Gnjidic D Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1367-1382. PubMed ID: 34311630 [No Abstract] [Full Text] [Related]
5. Deprescribing in older people. Page AT; Potter K; Clifford R; Etherton-Beer C Maturitas; 2016 Sep; 91():115-34. PubMed ID: 27451330 [TBL] [Abstract][Full Text] [Related]
6. Deprescribing Hypertension Medication in Older Adults: Can It Lower Drug Burden Without Causing Harm? Oliveira MG; Moreira PM; Amorim WW; Boockvar K Clin Geriatr Med; 2024 Nov; 40(4):659-668. PubMed ID: 39349038 [TBL] [Abstract][Full Text] [Related]
7. Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review. Ulley J; Harrop D; Ali A; Alton S; Fowler Davis S BMC Geriatr; 2019 Jan; 19(1):15. PubMed ID: 30658576 [TBL] [Abstract][Full Text] [Related]
8. Deprescribing: A Prime Opportunity to Optimize Care of Cancer Patients. Chaput G; Bhanabhai H Curr Oncol; 2023 Nov; 30(11):9701-9709. PubMed ID: 37999124 [TBL] [Abstract][Full Text] [Related]
9. A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms. Reeve E; Moriarty F; Nahas R; Turner JP; Kouladjian O'Donnell L; Hilmer SN Expert Opin Drug Saf; 2018 Jan; 17(1):39-49. PubMed ID: 29072544 [TBL] [Abstract][Full Text] [Related]
10. Using Deprescribing Practices and the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions Criteria to Reduce Harm and Preventable Adverse Drug Events in Older Adults. Earl TR; Katapodis ND; Schneiderman SR; Shoemaker-Hunt SJ J Patient Saf; 2020 Sep; 16(3S Suppl 1):S23-S35. PubMed ID: 32809998 [TBL] [Abstract][Full Text] [Related]
12. A-TAPER: A Framework for Deprescribing Medications effectively. Armistead LT; Sanders KA; Larson CK; Busby-Whitehead J; Ferreri SP Res Social Adm Pharm; 2022 Aug; 18(8):3358-3361. PubMed ID: 34930683 [TBL] [Abstract][Full Text] [Related]
13. Deprescribing medications in older people: a narrative review. Salahudeen MS Drugs Today (Barc); 2018 Aug; 54(8):489-498. PubMed ID: 30209443 [TBL] [Abstract][Full Text] [Related]
14. New horizons in deprescribing for older people. Woodford HJ; Fisher J Age Ageing; 2019 Nov; 48(6):768-775. PubMed ID: 31595290 [TBL] [Abstract][Full Text] [Related]
15. Antihypertensive treatment in people of very old age with frailty: time for a paradigm shift? Shantsila E; Lip GYH; Shantsila A; Kurpas D; Beevers G; Gill PS; Williams NH J Hypertens; 2023 Oct; 41(10):1502-1510. PubMed ID: 37432893 [TBL] [Abstract][Full Text] [Related]
17. Adverse Drug Events in Older Adults: Review of Adjudication Methods in Deprescribing Studies. Ross MSc Candidate SB; Wu PE; Atique Md Candidate A; Papillon-Ferland L; Tamblyn R; Lee TC; McDonald EG J Am Geriatr Soc; 2020 Jul; 68(7):1594-1602. PubMed ID: 32142161 [TBL] [Abstract][Full Text] [Related]
18. The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial. Bayliss EA; Shetterly SM; Drace ML; Norton J; Green AR; Reeve E; Weffald LA; Wright L; Maciejewski ML; Sheehan OC; Wolff JL; Gleason KS; Kraus C; Maiyani M; Du Vall M; Boyd CM Trials; 2020 Jun; 21(1):542. PubMed ID: 32552857 [TBL] [Abstract][Full Text] [Related]
19. Barricades and brickwalls--a qualitative study exploring perceptions of medication use and deprescribing in long-term care. Palagyi A; Keay L; Harper J; Potter J; Lindley RI BMC Geriatr; 2016 Jan; 16():15. PubMed ID: 26767619 [TBL] [Abstract][Full Text] [Related]
20. Deprescribing: A narrative review of the evidence and practical recommendations for recognizing opportunities and taking action. Reeve E; Thompson W; Farrell B Eur J Intern Med; 2017 Mar; 38():3-11. PubMed ID: 28063660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]